Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
80,000
-1.56%
|
$32,080,000
$401.88 P/Share
|
|
Mar 01
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
80,000
-1.56%
|
$32,080,000
$401.88 P/Share
|
|
Mar 01
2024
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
350
-2.56%
|
$140,000
$400.79 P/Share
|
|
Feb 29
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
20,000
-0.39%
|
$7,860,000
$393.71 P/Share
|
|
Feb 29
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-0.39%
|
$7,860,000
$393.71 P/Share
|
|
Feb 29
2024
|
Stephen P Ewald General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,163
-7.83%
|
$457,059
$393.5 P/Share
|
|
Feb 29
2024
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
2,558
-40.08%
|
$1,005,294
$393.5 P/Share
|
|
Feb 28
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$202,500
$405.0 P/Share
|
|
Feb 28
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$27,000
$54.99 P/Share
|
|
Feb 28
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.96%
|
$20,200,000
$404.13 P/Share
|
|
Feb 28
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.96%
|
$20,200,000
$404.13 P/Share
|
|
Feb 27
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.96%
|
$20,050,000
$401.88 P/Share
|
|
Feb 27
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.96%
|
$20,050,000
$401.88 P/Share
|
|
Feb 26
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
500
-74.6%
|
$202,000
$404.29 P/Share
|
|
Feb 26
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$27,000
$54.99 P/Share
|
|
Feb 26
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
56,928
-1.08%
|
$22,885,056
$402.38 P/Share
|
|
Feb 26
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
56,928
-1.08%
|
$22,885,056
$402.38 P/Share
|
|
Feb 23
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.86%
|
$40,000,000
$400.32 P/Share
|
|
Feb 23
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.86%
|
$40,000,000
$400.32 P/Share
|
|
Feb 22
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-1.82%
|
$39,500,000
$395.98 P/Share
|
|
Feb 22
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-1.82%
|
$39,500,000
$395.98 P/Share
|
|
Feb 21
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
36,012
-0.65%
|
$13,792,596
$383.44 P/Share
|
|
Feb 21
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
36,012
-0.65%
|
$13,792,596
$383.44 P/Share
|
|
Feb 20
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,782
+38.96%
|
$358,332
$26.44 P/Share
|
|
Feb 20
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,988
-0.25%
|
$5,399,368
$386.39 P/Share
|
|
Feb 20
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
13,988
-0.25%
|
$5,399,368
$386.39 P/Share
|
|
Feb 16
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.89%
|
$19,550,000
$391.75 P/Share
|
|
Feb 16
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.89%
|
$19,550,000
$391.75 P/Share
|
|
Feb 08
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,710
+48.32%
|
$268,470
$57.17 P/Share
|
|
Dec 31
2023
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103
+1.3%
|
-
|
|
Dec 31
2023
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+20.0%
|
-
|
|
Dec 31
2023
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
94
+20.0%
|
-
|
|
Dec 15
2023
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
2,009
-11.62%
|
$608,727
$303.0 P/Share
|
|
Dec 14
2023
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
10,391
-37.54%
|
$3,158,864
$304.15 P/Share
|
|
Dec 01
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
24,039
-0.43%
|
$6,562,647
$273.26 P/Share
|
|
Dec 01
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
24,039
-0.43%
|
$6,562,647
$273.26 P/Share
|
|
Nov 30
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,871
-0.14%
|
$2,140,912
$272.18 P/Share
|
|
Nov 30
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
7,871
-0.14%
|
$2,140,912
$272.18 P/Share
|
|
Nov 29
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,257
-0.19%
|
$5,781,904
$272.74 P/Share
|
|
Nov 29
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
21,257
-0.19%
|
$5,781,904
$272.74 P/Share
|
|
Nov 28
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
21,833
-0.39%
|
$5,960,409
$273.66 P/Share
|
|
Nov 28
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,833
-0.39%
|
$5,960,409
$273.66 P/Share
|
|
Nov 27
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,900,000
$276.1 P/Share
|
|
Nov 27
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,900,000
$276.1 P/Share
|
|
Nov 22
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,925,000
$277.81 P/Share
|
|
Nov 22
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,925,000
$277.81 P/Share
|
|
Nov 21
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.44%
|
$6,925,000
$277.37 P/Share
|
|
Nov 21
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.44%
|
$6,925,000
$277.37 P/Share
|
|
Nov 20
2023
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.86%
|
$13,750,000
$275.45 P/Share
|
|
Nov 20
2023
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.86%
|
$13,750,000
$275.45 P/Share
|